 |
12th Annual CTOS Meeting
|
 |
Image guided surgery:
New technology for surgery of soft tissue
and bone sarcomas
|
 |
The Radiation Response of Sarcomas by
Histologic Subtypes: A Review With Special Emphasis Given to Results
Achieved With Razoxane |
 |
Alveolar soft-part
sarcoma: a review and update
|
 |
Liposarcoma
in adult limbs treated by limb-sparing surgery and adjuvant
radiotherapy |
 |
The SYT-SSX fusion
protein down-regulates the cell proliferation regulator COM1 in
t(x;18) synovial sarcoma
|
 |
Combined Transcriptional and Translational Targeting
of EWS/FLI-1 in Ewing's Sarcoma |
 |
NR0B1 Is Required
for the Oncogenic Phenotype Mediated by EWS/FLI in Ewing's Sarcoma
|
 |
Caveolin-1 (CAV1)
Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic
Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
|
 |
Complications Associated with Neoadjuvant Radiotherapy in the
Multidisciplinary Treatment of Retroperitoneal Sarcomas
|
 |
A review of vaccine clinical
trials for non-small cell lung cancer |
 |
Staging of Primary Malignancies of Bone
|
 |
Quality of Life
After Hyperthermic Isolated Limb Perfusion for Locally Advanced
Extremity Soft Tissue Sarcoma
|
 |
A Phase II Trial
of Isolated Limb Infusion With Melphalan and Dactinomycin for
Regional Melanoma and Soft Tissue
Sarcoma of the Extremity |
 |
Use of Distal Femoral Osteoarticular Allografts in
Limb Salvage Surgery |
 |
Wild-type p53 Inhibits Nuclear Factor-κB–Induced
Matrix Metalloproteinase-9 Promoter Activation: Implications for
Soft Tissue Sarcoma Growth and Metastasis
|
 |
Osteoclasts Direct
Bystander Killing of Bone Cancer
|
 |
Prognostic factors and expression of p53 and mdm-2 in uterine
sarcomas |
 |
World's Largest Clinical Trial Into Osteosarcoma Well Underway
Conference Hears
|
 |
Protocol for the
Examination of Specimens From Patients With Soft Tissue Tumors of
Intermediate Malignant Potential, Malignant Soft Tissue Tumors, and
Benign/Locally Aggressive and Malignant Bone Tumors
|
 |
Longer Infusion Times for
Anthracyclines Reduce Cardiac Damage |
 |
Electroporation
Therapy in Soft Tissue Sarcoma: A Potentially Effective Novel
Treatment
|
 |
NIH Director's Pioneer Award
|
 |
NIH Announces
Licensing Opportunities for Rare Disease Technologies
|
 |
Patients'
Views on Financial Conflicts of Interest in Cancer Research Trials
|